Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd.
2025 Annual Independent Director's Report
As an independent director of Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), I have strictly complied with the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Administrative Measures for Independent Directors of Listed Companies," and "Shenzhen Stock Exchange Main Board Listed Company Standardized Operation Guide No. 1," as well as other relevant laws, administrative regulations, normative documents, and the "Articles of Association" and "Company's Independent Director Work System." I have conscientiously, diligently, and independently fulfilled my duties, effectively played the role of an independent director, and earnestly protected the legitimate rights and interests of the Company and all shareholders. The following is a report on my fulfillment of duties in 2025:
I. Basic Information of the Independent Director
I am Hu Jian, male, born in July 1968, a Chinese national with no overseas residency. I hold a doctoral degree. From June 1989 to July 1993, I pursued my undergraduate studies in Law at Southwest Normal University. From September 1999 to July 2002, I pursued my master's degree in Civil and Commercial Law (Commercial Law direction) at Southwest University of Political Science and Law. From September 2002 to January 2011, I pursued my doctoral degree in Civil and Commercial Law (Intellectual Property Law direction) at Southwest University of Political Science and Law. From July 2014 to December 2014, I was a visiting scholar at the University of Chicago in the United States. Since September 1993, I have been a professor at the School of Economics and Business Administration, Chongqing University.